Laurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 18060.97 Crore) operating in Pharmaceuticals sector.
Laurus Labs key Products/Revenue Segments include Pharmaceutical Products, Traded Goods, Contract Service, Other Operating Revenue, Scrap for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 1382.61 Crore, down -10.58 % from last quarter Total Income of Rs 1546.25 Crore and down -3.05 % from last year same quarter Total Income of Rs 1426.12 Crore. Company has reported net profit after tax of Rs 107.24 Crore in latest quarter.
The company’s top management includes Dr.M Venu Gopala Rao, Dr.C V Lakshmana Rao, Dr.Satyanarayana Chava, Mr.V V Ravi Kumar, Mr.Chandrakanth Chereddi, Dr.Ravindranath Kancherla, Mrs.Aruna Rajendra Bhinge, Dr.Rajesh Koshy Chandy. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2023, the company has a total of 54 Crore shares outstanding.
Price close above previous intermediate highs signaling further upsides in coming sessions.
Promoter/FII Holdings
Promoters held 27.2 per cent stake in the company as of 31-Mar-2023, while FIIs owned 22.42 per cent, DIIs 9.74 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price